How to treat refractory OAB using injectable botulinum toxin

No patient has developed urinary retention or elevated post-void residuals following our modified injection technique.

Related Content:

Drug Therapy

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria